HKU Scholars Hub: Browsing DSpace

Browsing by Author Tan, EH

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 8 of 8

	Title	Author(s)	Issue Date	Views
	10-Year Outcome on the Efficacy and Late Toxicities Attributed to the Addition of Concurrent-Adjuvant Chemotherapy for Stage III-IVB Nasopharyngeal Carcinoma (Combined Analyses of the NPC-9901 and NPC-9902 Trials) Proceeding/Conference:International Journal of Radiation Oncology - Biology - Physics	Lee, WMA Tung, SY Ng, WT Ngan, KC Lee, VHF Choi, CW Chan, L Lu, TX Siu, LL Tan, TWK Ng, AWY Yiu, HHY Leung, TW O'Sullivan, B Tan, EH Chappell, RJ	2017	114
	A Phase IIIb open-label, single-arm study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC: An interim analysis. Proceeding/Conference:World Lung Cancer Conference, 2017	Wu, YL Tu, H Feng, J Shi, M Zhao, J Wang, Y Chang, J Wang, J Cheng, Y Zhu, J Tan, EH Li, K Zhang, Y Lee, VHF Yang, CT Su, WC Lam, CLD Srinivasa, BJ Rajappa, S Ho, CL Lam, KC Hu, Y Bondarde, SA Liu, XQ Fan, J Kuo, D Wang, Y Pang, K Zhou, C	2017	109
	A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China Journal:Targeted Oncology	Tu, HY Feng, J Shi, M Zhao, J Wang, Y Chang, J Wang, J Cheng, Y Zhu, J Tan, EH Li, K Zhang, Y Lee, V Yang, CT Su, WC Lam, CLD Srinivasa, BJ Rajappa, S Ho, CL Lam, KC Hu, Y Bondarde, SA Liu, X Tian, Y Xue, Z Cseh, A Huang, DC Zhou, C Wu, YL	2022
	Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies Journal:Frontiers in Oncology	Passaro, A de Marinis, F Tu, HY Laktionov, KK Feng, J Poltoratskiy, A Zhao, J Tan, EH Gottfried, M Lee, V Kowalski, D Yang, CT Srinivasa, BJ Clementi, L Jalikop, T Huang, DCL Cseh, A Park, K Wu, YL	2021	19
	Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study Proceeding/Conference:European Society for Medical Oncology (ESMO) Asia Congress, 2017	Mok, T Peter, S Camidge, DR Ou, SH Ahn, JS Tan, EH Li, Z Lee, JS Cho, BC Geater, S Sriuranpong, V Ho, JCM Chan, SH Zeiter, A Balas, B Nueesch, E Mitry, E Morcos, PN Kim, DW	2017	46
	Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma—Exploration for Achieving Optimal 10-Year Therapeutic Ratio Journal:International Journal of Radiation Oncology - Biology - Physics	Ng, WT Tung, SY Lee, VHF Ngan, KCR Choi, CW Chan, LLK Leung, TW Siu, LL Lu, TX Tan, T Tan, EH Sze, CKH Ng, AWY Yiu, HHY O'Sullivan, B Chappell, R Lee, WMA	2018	78
	Impact of epidermal growth factor receptor inhibitor in non-small cell lung cancer on progression-free an overall survival: a meta-analysis Journal:Journal of the National Cancer Institute	Lee, CH Brown, C Gralla, R Hirsh, V Thongprasert, S Tsai, CM Tan, EH Ho, JCM Chu, DT Zaatar, A Sanchez, JO Vu, VV Au, JSK Inoue, A Lee, SM Gebski, V Yang, JCH	2013	45
	A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaïve patients with metastatic or locally advanced non-small cell lung cancer Journal:Respiratory Medicine	Ho, JCM Tan, EH Leong, SS Wang, CH Sun, Y Li, R Wahid, MIA Jusuf, A Liao, M Guan, Z Handoyo, P Huang, JS Chan, V Luna, G Tsang, KWT Lam, WK	2003	168

Showing results 1 to 8 of 8